As stated previously, TLSs have been shown to associate with improved survival in response to immunotherapies.11,32 Our data on OX40+ Tregs and OX40+ CD4s, as TLS-associated or TLS-independent, provides further insight into the complexity of the immune contexture of TLSs in sarcoma. This evidence concerns the gene TNFRSF4 and sarcoma.